EV/EBITDA:
-23.86+0.67(+2.73%)Summary
- As of today, TRVI EV/EBITDA is -23.86, with a rise of +0.67 (+2.73%) during the most recent trading session on November 19, 2025.
- Over the past year, TRVI EV/EBITDA has dropped by -20.40 (-589.60%).
- TRVI EV/EBITDA is now -3120.25% below its all-time high of 0.79.
Performance
TRVI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TRVI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +2.7% | -2.8% | -2.4% |
| 1M1 Month | -7.7% | +7.7% | +6.6% |
| 3M3 Months | -78.1% | +77.5% | +50.8% |
| 6M6 Months | -117.9% | +118.9% | +70.1% |
| YTDYTD | -339.4% | +337.8% | +168.0% |
| 1Y1 Year | -589.6% | +634.9% | +268.0% |
| 5Y5 Years | -4318.5% | +7479.1% | +268.0% |
TRVI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -22.15 | -7.7% | -26.51 | +10.0% |
| 3M | 3-Month | -12.67 | -88.3% | -26.51 | +10.0% |
| 6M | 6-Month | -9.01 | -164.8% | -26.51 | +10.0% |
| 1Y | 1-Year | -2.64 | -803.8% | -26.51 | +10.0% |
| 3Y | 3-Year | 0.62 | -3948.4% | -26.51 | +10.0% |
| 5Y | 5-Year | 0.79 | -3120.3% | -26.51 | +10.0% |
| All-Time | All-Time | 0.79 | -3120.3% | -26.51 | +10.0% |
TRVI EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -23.86(-339.4%) |
| 2024 | -5.43(-1772.4%) |
| 2023 | -0.29(-93.3%) |
| Date | Value |
|---|---|
| 2022 | -0.15(-1400.0%) |
| 2021 | -0.01(+97.7%) |
| 2020 | -0.44 |
FAQ
- What is Trevi Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Trevi Therapeutics, Inc.?
- What is TRVI EV/EBITDA year-to-date change?
- What is Trevi Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Trevi Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TRVI is -23.86
What is the all-time high EV/EBITDA for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high EV/EBITDA is 0.79
What is TRVI EV/EBITDA year-to-date change?
Trevi Therapeutics, Inc. EV/EBITDA has changed by -18.43 (-339.41%) since the beginning of the year
What is Trevi Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TRVI EV/EBITDA has changed by -20.40 (-589.60%)